Physician profile
Edward S Lee
NPI 1114926672
$1,407.41
in general payments reported to CMS, 2019-2025
9 companies · $394 in 2025
The $394 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $234 · 2020: $77.75 · 2021: $67.62 · 2022: $283 · 2023: $333 · 2024: $18.60 · 2025: $394.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $383 · Travel and Lodging: $363.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $382.59 |
| Travel and Lodging | $363.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $744.19 | 2019-2025 | |
| Smith+Nephew, INC. | $378.17 | 2023-2025 | Tula, Rf20000 |
| Glaxosmithkline, LLC. | $82.91 | 2022-2025 | Nucala |
| Intersect Ent, INC. | $52.38 | 2019-2020 | |
| Hikma Pharmaceuticals USA | $36.35 | 2023 | Ryaltris |
| Acclarent, INC | $34.14 | 2020-2022 | |
| Stryker Corporation | $28.83 | 2019 | |
| Aroa Biosurgery Incorporated | $27.47 | 2023 | |
| Novartis Pharmaceuticals Corporation | $22.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.